The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential

GW Zamponi, J Striessnig, A Koschak… - Pharmacological …, 2015 - Elsevier
Voltage-gated calcium channels are required for many key functions in the body. In this
review, the different subtypes of voltage-gated calcium channels are described and their …

In vitro models of the blood–brain barrier: an overview of commonly used brain endothelial cell culture models and guidelines for their use

HC Helms, NJ Abbott, M Burek… - Journal of Cerebral …, 2016 - journals.sagepub.com
The endothelial cells lining the brain capillaries separate the blood from the brain
parenchyma. The endothelial monolayer of the brain capillaries serves both as a crucial …

Blood-brain barrier and delivery of protein and gene therapeutics to brain

WM Pardridge - Frontiers in aging neuroscience, 2020 - frontiersin.org
Alzheimer's disease (AD) and treatment of the brain in aging require the development of
new biologic drugs, such as recombinant proteins or gene therapies. Biologics are large …

Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale

JSW Hong, LZ Atkinson, N Al-Juffali, A Awad… - Molecular …, 2022 - nature.com
The gabapentinoids, gabapentin, and pregabalin, target the α2δ subunits of voltage-gated
calcium channels. Initially licensed for pain and seizures, they have become widely …

L-Type amino acid transporter 1 as a target for drug delivery

E Puris, M Gynther, S Auriola, KM Huttunen - Pharmaceutical research, 2020 - Springer
Our growing understanding of membrane transporters and their substrate specificity has
opened a new avenue in the field of targeted drug delivery. The L-type amino acid …

SLC and ABC transporters: expression, localization, and species differences at the blood-brain and the blood-cerebrospinal fluid barriers

ME Morris, V Rodriguez-Cruz, MA Felmlee - The AAPS journal, 2017 - Springer
The blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSFB) separate
the brain and cerebrospinal fluid (CSF) from the systemic circulation and represent a barrier …

Targeting transporters for drug delivery to the brain: can we do better?

E Puris, G Fricker, M Gynther - Pharmaceutical Research, 2022 - Springer
Limited drug delivery to the brain is one of the major reasons for high failure rates of central
nervous system (CNS) drug candidates. The blood–brain barrier (BBB) with its tight …

[HTML][HTML] The solute carrier transporters and the brain: Physiological and pharmacological implications

C Hu, L Tao, X Cao, L Chen - Asian journal of pharmaceutical sciences, 2020 - Elsevier
Solute carriers (SLCs) are the largest family of transmembrane transporters that determine
the exchange of various substances, including nutrients, ions, metabolites, and drugs across …

[HTML][HTML] The barrier and interface mechanisms of the brain barrier, and brain drug delivery

S Zhang, L Gan, F Cao, H Wang, P Gong, C Ma… - Brain Research …, 2022 - Elsevier
Three different barriers are formed between the cerebrovascular and the brain parenchyma:
the blood-brain barrier (BBB), the blood-cerebrospinal fluid barrier (BCSFB), and the …

Insights into the structure, function, and ligand discovery of the large neutral amino acid transporter 1, LAT1

N Singh, GF Ecker - International journal of molecular sciences, 2018 - mdpi.com
The large neutral amino acid transporter 1 (LAT1, or SLC7A5) is a sodium-and pH-
independent transporter, which supplies essential amino acids (eg, leucine, phenylalanine) …